In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Alife Health Leverages AI For IVF To Increase Access To Care And Chances Of Success

Executive Summary

One in eight couples in the US are struggling to get pregnant. Alife Health’s CEO Paxton Maeder-York believes that by leveraging artificial intelligence for use in IVF fertility clinics, he can help shape a future where more people have a better chance of starting families at a lower cost and higher rate of success.

You may also be interested in...



Alife Health Leverages AI Tools For IVF To Increase Access, Improve Chances For Successful Pregnancies

One in eight couples in the US are struggling to get pregnant. Alife Health’s CEO Paxton Maeder-York believes that by leveraging artificial intelligence for use in IVF fertility clinics, he can help shape a future where more people have a better chance of starting families at a lower cost and higher rate of success.

Lux Capital’s Deena Shakir Bullish On Women’s Health: ‘Fundamentally A Massive Market Opportunity’

Medtech Insight talked with Lux Capital’s general partner Deena Shakir about her investments in women’s health, untapped opportunities and barriers, gender equality in investment, and her outlook for investment in women’s health.

Canary Speech’s Voice AI Can Help Detect Alzheimer’s With 40-Second Conversation

AI voice tech start-up Canary Speech is developing algorithmic models for detecting behavioral health, progressive neurological and cognitive diseases based on a 40-second recording of speech. Medtech Insight caught up with Canary CEO Henry O’Connell at DHIS West to learn more about the company and its plans.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

IV147717

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel